Immune response in critically ill patients suffering from pneumonia

Immune response in critically ill patients suffering from pneumonia - PneumoSept

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027833

Enrollment

Registered

2022-01-20

Start date

2022-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia sepsis

Interventions

Group 1: Analysis of blood samples from critically ill patients suffering from pneumonia

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Inpatient treatment in one of the participating intensive care units - Presence of a diagnosis of pneumonia on admission or during the course of treatment - Community acquired pneumonia (CAP) - Hospital acquired pneumonia (HAP) - Ventilator acquired pneumonia (VAP) - Signed declaration of consent by the patient or alternatively by the legal representative in case of full legal capacity - Completion of the 18th year of life

Exclusion criteria

Exclusion criteria: The following criteria lead to the exclusion or not possible inclusion of patients: - Lack of informed consent - Missing pneumonia diagnosis - Patient included in an intervention study - Contraindication for further blood collection (acute bleeding etc.) - Absence of an inserted catheter suitable for collection - Patient age under 18 years

Design outcomes

Primary

Measure	Time frame
Secondary Infection Sepsis (Diagnosis made by intensive care physician)	—

Secondary

Measure	Time frame
Inflammatory markers	—

Countries

Germany

Contacts

Public ContactSteffen Dickel

Klinik für AnästhesiologieUniversitätsmedizin Göttingen

steffen.dickel@med.uni-goettingen.de+4955166045

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026